Iodure [123i] De Sodium Cis Bio International (Sodium Iodide (123 I))

Sodium Iodide, the active ingredient in Iodure [123i] De Sodium Cis Bio International, is a diagnostic radiopharmaceutical presented as a sterile aqueous solution for intravenous use. It is employed to visualize thyroid tissue and assess its functional status in patients undergoing nuclear medicine examinations.

GNH USA supplies Iodure [123i] De Sodium Cis Bio International as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iodure [123i] De Sodium Cis Bio International is a radiopharmaceutical used in thyroid‑related diagnostic pathways. - Thyroid imaging: provides functional and anatomical assessment of thyroid tissue for routine scans. - Thyroid nodule evaluation: helps differentiate benign from malignant nodules by measuring iodine uptake. - Thyroid cancer staging: assists in detecting residual or metastatic disease after treatment.

Adverse reactions may occur following administration of Iodure [123i] De Sodium Cis Bio International.

Common Side Effects: - Nausea or vomiting: mild gastrointestinal upset after injection. - Injection site pain or erythema: transient discomfort at the venipuncture site. - Headache: brief, self‑limiting headache reported by some patients.

Serious or Rare Side Effects: - Allergic reaction: urticaria, bronchospasm, or anaphylaxis requiring immediate medical attention. - Radiation thyroiditis: inflammation of the thyroid gland due to radiation exposure. - Severe hypotension: rare drop in blood pressure following rapid intravenous administration.

Prior to using Iodure [123i] De Sodium Cis Bio International, consider the following safety measures. - Pregnancy: risk unknown; avoid unless clearly needed. - Breastfeeding: risk unknown; consider discontinuation during treatment. - Thyroid function: assess baseline thyroid status before administration. - Renal impairment: monitor renal function as clearance may be affected. - Iodine allergy: screen patients for known hypersensitivity to iodine compounds. - Store at ambient temperature: keep in original shielded container, protect from light and moisture.

Iodure [123i] De Sodium Cis Bio International may interact with other agents.

Major Interactions (Avoid): - Thyroid hormone therapy: can reduce radiotracer uptake and compromise imaging quality. - Antithyroid drugs (e.g., methimazole, propylthiouracil): diminish iodine uptake, leading to false‑negative results. - Iodine‑containing contrast agents: block thyroid uptake if administered within 2–4 weeks.

Moderate Interactions (Monitor Closely): - Lithium therapy: may alter thyroid iodine handling and affect image interpretation. - Amiodarone: high iodine load can interfere with tracer distribution. - Diuretics: may affect renal clearance of the radiopharmaceutical, requiring monitoring.